JPMorgan offers leveraged notes tied to MerQube index
JPMorgan Chase Financial Company LLC, fully guaranteed by JPMorgan Chase & Co., is offering Uncapped Accelerated Barrier Notes linked to the MerQube US Large-Cap Vol Advantage Index, maturing on September 17, 2031.
Rhea-AI Filing Summary
JPMorgan Chase Financial Company LLC, fully guaranteed by JPMorgan Chase & Co., is offering Uncapped Accelerated Barrier Notes linked to the MerQube US Large-Cap Vol Advantage Index, maturing on September 17, 2031. The notes target at least 3.00x any positive Index return at maturity, with no upside cap.
The structure includes a Barrier Amount at 60.00% of the Initial Value. If the Final Index Value is at or above this barrier, principal is repaid; if it falls below, investors lose 1% of principal for every 1% Index decline, potentially losing the entire investment. The underlying Index applies a 6.0% per annum daily deduction, which drags on performance and can cause the Index to underperform comparable strategies without such a fee.
The notes pay no interest, provide no dividend exposure to S&P 500 constituents, and are unsecured, unsubordinated obligations of JPMorgan Financial, subject to the credit risk of both JPMorgan Financial and JPMorgan Chase & Co. An indicative estimated value is $868.40 per $1,000 note, and will not be less than $850.00 at pricing.
Positive
- None.
Negative
- None.
Filing Explained
No common-share dilution is disclosed; final leverage and offering economics await the expected August 27, 2026 pricing.
The July 29, 2026 pricing supplement describes an offering of unsecured, unsubordinated notes issued by JPMorgan Chase Financial Company LLC and fully guaranteed by JPMorgan Chase & Co. The offering remains subject to completion, with pricing expected on or about
Because the security is described as notes rather than common stock, the filing does not describe an equity issuance or dilution of existing common holders.
The final Upside Leverage Factor is still to be provided in the pricing supplement, while the price to public, fees and commissions, and proceeds to the issuer are blank in this document. The filing therefore establishes the product framework but not the final offering economics or issuer proceeds.
The company discloses that an affiliate owns approximately
The notes will not be listed on a securities exchange, and the filing states that holders may not be able to sell them; any secondary-market repurchase would depend on JPMS's willingness to buy.
The next state-changing disclosures are the final pricing supplement and the expected pricing and settlement dates, which should establish the remaining leverage, valuation and issuance terms.
Key Figures
Key Terms
Barrier Amount financial
Upside Leverage Factor financial
target volatility financial
excess return index financial
contango financial
volatility drag financial
Offering Details
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the key terms of JPMorgan AMJB Uncapped Accelerated Barrier Notes?
How is the MerQube US Large-Cap Vol Advantage Index used in these AMJB notes?
What happens at maturity of the JPMorgan AMJB notes if the Index falls?
Do the JPMorgan AMJB notes pay interest or dividends during their term?
What is the estimated value of the JPMorgan AMJB notes at issuance?
What credit risks do investors in JPMorgan AMJB notes face?
AI-generated analysis. How Rhea-AI works. Not financial advice.